Back to search
CVE-2017-17678
Published: May 19, 2021
Modified: Aug 5, 2024
PUBLISHED
Description
BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.
| Vendor | Product | Versions |
|---|---|---|
n/a | n/a | affected n/a |
References
http://bmc.com
x_refsource_MISC
http://remedy.com
x_refsource_MISC
https://seclists.org/fulldisclosure/2017/Oct/52
x_refsource_MISC
Security Training
Train your team to recognize and prevent security threats with our comprehensive security awareness program.
Start TrainingVulnerability Scanning
Discover vulnerabilities in your applications and infrastructure before attackers do.
Scan Now